The Valley Desk

NCT05769777 · Interventional trial

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Overall registry status Active not recruiting

Phase 2

Conditions Dermatitis Atopic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov